aDepartment of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD; and
bDivision of Infectious Disease, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD.
Reprints: Robert V. O'Toole, MD, Department of Orthopaedics, R Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, 22 S. Greene St, T1R77, Baltimore, MD 21201 (e-mail [email protected]).
Supported in part by a fellow research grant from AO North America. R. V. O'Toole is a paid consultant for CoorsTek, Imagen, and Smith & Nephew, receives stock options from Imagen, and receives royalties from CoorsTek, unrelated to this study. M. Joshi receives grant funding from Synthes and Atox and personal fees from Pfizer for activities outside the submitted work.
The authors report no conflict of interest.
Presented as a poster at the Annual Meeting of the AAOS, March 1–5, 2016, Orlando, FL. Presented in part at the Annual Meeting of the Orthopaedic Trauma Association, October 10, 2015, San Diego, CA.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jorthotrauma.com).
